Intox Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 7.60 M
as on 04-07-2024
- Company Age 24 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.91 Cr
as on 04-07-2024
- Revenue 46.06%
(FY 2022)
- Profit 184.96%
(FY 2022)
- Ebitda 40.17%
(FY 2022)
- Net Worth 65.21%
(FY 2022)
- Total Assets 34.23%
(FY 2022)
About Intox
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.60 M.
The company has closed loans amounting to ₹2.91 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Intox Private Limited India is Subhash Nalajala as COMPANY SECRETARY. Ajay Srivastava, Narendra Deshmukh, Mukul Pore, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999PN2000PTC015116
- Company No.
015116
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2000
- Date of AGM
07 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Intox?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhash Nalajala | Company Secretary | 13-Dec-2021 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Srivastava  | Director | 13-Dec-2021 | Current |
| Narendra Deshmukh | Director | 05-Jan-2024 | Current |
| Mukul Pore | Director | 17-Jul-2000 | Current |
| Manmahesh Kantipudi | Director | 25-Apr-2023 | Current |
Financial Performance and Corporate Structure Insights of Intox.
Intox Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.06% increase. The company also saw a substantial improvement in profitability, with a 184.96% increase in profit. The company's net worth Soared by an impressive increase of 65.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intox?
In 2022, Intox had a promoter holding of 98.68% and a public holding of 1.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aragen Life Sciences LimitedActive 24 years 13 daysAjay Srivastava and Manmahesh Kantipudi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jul 2020 | ₹0.06 M | Satisfied |
Others Creation Date: 21 Dec 2015 | ₹2.20 Cr | Satisfied |
The Saraswat Co-Operative Bank Limited Creation Date: 04 Mar 2003 | ₹7.00 M | Satisfied |
How Many Employees Work at Intox?
Intox has a workforce of 118 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intox, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intox's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
